Live Breaking News & Updates on Psychopharmacologic drugs

Stay updated with breaking news from Psychopharmacologic drugs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug? | Dementia and Cognitive Impairment | JAMA

This Medical News story examines the complexity of determining who to treat with lecanemab, the new Alzheimer disease drug.

United-kingdom , Ohio , United-states , New-york , Kansas , Minnesota , George-perry , Donna-wilcock , Eli-lilly , Russell-swerdlow , James-burke , Sam-grandy